THE NEW ERA OF TREATING SCHIZOPHRENIA

Summary from the TLDR newsletter

Schizophrenia is one of the costliest mental health illnesses - it costs nearly $300 billion dollars in healthcare spending annually despite affecting less than 1% of the population. It is currently treated with antipsychotics, a treatment discovered through pure chance. Regulators are currently deciding whether to approve a drug with a novel mechanism for treating schizophrenia. The new drug has opened up a new hypothesis for schizophrenia, which multiple biotech companies are pursuing.